Assessment of effectiveness of Evogliptin plus metformin added to insulin therapy in terms of safely improving the glycemic control for elderly Type 2 Diabetes Mellitus patients in India
Latest Information Update: 10 Aug 2021
At a glance
- Drugs Evogliptin (Primary) ; Metformin (Primary) ; Insulin; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 10 Aug 2021 New trial record
- 29 Jun 2021 Results presented at the 81st Annual Scientific Sessions of the American Diabetes Association